PHM

PHARMA MAR, S.A.

Stock Bolsas y Mercados Españoles – Stock Market Prices, News & Analysis

Pharma Mar, S.A. is a biopharmaceutical company specializing in the research, development, and commercialization of marine-derived anticancer compounds.

€ 94.65
2.37 %

PHARMA MAR, S.A.

94.65
2.37 %
PHM

Pharma Mar, S.A. is a biopharmaceutical company specializing in the research, development, and commercialization of marine-derived anticancer compounds.

Price history of PHARMA MAR, S.A.
Price history of PHARMA MAR, S.A.

Performance & Momentum

6 Months 22.99 %
1 Year 31.18 %
3 Years 146.88 %
5 Years 11.01 %

Strategic Analysis

PHARMA MAR, S.A. • 2026

Pharma Mar, S.A. stands out in the healthcare and biotechnology sector due to its focus on the development and commercialization of marine-based cancer treatments. Its innovative and specialized approach to oncology allows it to target specific therapeutic niches with original solutions.

Strengths
  • Specialization in oncology with unique marine-derived products
  • Strong position in research and development with innovative marine therapies
  • Notable presence in the international market, particularly in Spain
Weaknesses
  • High concentration in the oncology segment, which may limit diversification of revenue sources
Momentum

Pharma Mar's momentum shows a positive trend, highlighted by a notable appreciation over the past year. This progression suggests a strong reception of its innovative products in the market, as well as an increasing recognition of its unique specialties in the fight against cancer.

Similar stocks to PHARMA MAR, S.A.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone